LeonaBio FY 2025: net loss $105.6M; diluted EPS −$24.70

Key figures from this report

These are the numbers LeonaBio reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income−$105.6MAgainst −$96.9M in FY 202410-K income statement, on EDGAR
2. Diluted EPS−$24.70Against −$25.20 in FY 202410-K income statement, on EDGAR
3. Cash and cash equivalents$69.3M+43% from $48.4M in FY 2024Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
4. Cash from operations−$45.7MAgainst −$97.2M in FY 202410-K cash flow statement, on EDGAR

Every year in the financial tables